Serum Uric Acid Levels As A Prognostic Marker In Acute Heart Failure Patients
Author(s): Anies Siya KS, Shilpa Gaidhane*, Vinay Verma
Background: According to latest epidemiological and clinical research, serum uric acid can be one of the helpful indicators in determining the risk of mortality in acute heart failure. This study’s purpose is to correlate serum uric acid levels in patients with AHF and assess the prognostic relevance of SUA levels in those individuals. Aim & Objectives: The study’s main purpose is to see if serum uric acid levels could be used as a prognostic indicator in patients with acute heart failure. The study also focusses on the clinical profile of individuals with AHF as well as the amount of serum uric acid in AHF patients, the relation between serum uric acid levels, hospital stay length and mortality rate after release; and the risk variables associated with death in AHF patients. Methods: The study will be a nine-month cross-sectional study with a six-month follow-up from June 2021 to February 2022. The study will enroll approximately 253 patients with AHF, both new-onset and acute decompensation of chronic heart failure, in the hospital's Medicine ICU. Conclusion: The measurement of SUA levels may help to confirm the risk of unfavourable outcomes in patients with AHF. The reduction of uric acid can be expected to be a novel strategy to HF prevention and treatment.